More Young Adults Than Ever Take HIV-Prevention Medication, but Gaps Remain

More Young Adults Than Ever Take HIV-Prevention Medication, but Gaps Remain

Eight times more American young adults now take medication to protect them from HIV than a decade ago, a new study of pre-exposure prophylaxis or PrEP finds. This type of care is the subject of a Supreme Court case.

Record Number of Young Adults Use HIV-Prevention Medication, Yet

Over the past decade, there has been a remarkable surge in the number of American young adults prescribed pre-exposure prophylaxis (PrEP), a medication regimen highly effective in preventing the transmission of human immunodeficiency virus (HIV). According to a groundbreaking study conducted by researchers at the University of Michigan Medical School, the frequency of PrEP prescriptions filled by individuals aged 18 to 25 has increased eightfold…

CROI 2025 Insights: Evolving HIV Treatment Landscape and Practice-Changing Developments

A panelist discusses how HIV treatment has evolved with tremendous improvements in efficacy, tolerability, and convenience, with exciting developments at the Conference on Retroviruses and Opportunistic Infections 2025, including new long-acting therapies for treatment and prevention that could last up to 2 years.